Warnings for Infant Head Support Devices

Summary#

Assembly Bill A-11721 would amend New York’s General Business Law by adding a warning-label requirement for certain infant head support devices. Its stated goal is to warn buyers that prolonged use may deform an infant’s skull and to advise limiting time against the product and repositioning the baby. The bill is introduced and is not law; passage is uncertain.

  • Manufacturers would have to ensure covered devices sold in New York carry the warning permanently on the device and on the main display panel of the retail packaging. The warning must be legible and at least 12-point type.
  • The bill covers products such as pillows, cushions, loungers, positioners, wedges, mats, and certain inserts, if designed, marketed, or intended to support or position an infant’s head. “Infant” means a child under 12 months.
  • The bill excludes certain prescribed, FDA-approved medical devices; components supplied by the original maker of a child restraint system to meet federal standards; and infant sleep products subject to a mandatory federal safety standard.
  • The Department of Health must create a model label. It may include a website link and may create a website with information about skull deformity and the benefits of carrying an infant.
  • The Attorney General may seek a court order to stop violations. A court may impose a civil penalty of up to $250 per violation for a first offense and up to $500 per violation for each later offense.
  • The bill would take effect 180 days after becoming law. It says these requirements do not limit other legal duties or liability.

What it means for you#

  • Manufacturers: You would be responsible for ensuring each covered device has the required warning on the device and its retail packaging.
  • Retailers and buyers: The requirement applies to covered devices offered for sale in New York. The bill places the express responsibility for ensuring the label is present on manufacturers; it does not create a separate retailer labeling duty.
  • Parents and caregivers: The warning would advise limiting the baby’s time resting against the product and repositioning the baby frequently. The bill does not set a time limit or specify how often to reposition.
  • Department of Health: It must create a model label, but the bill does not require it to create the optional website.
  • Attorney General: The Attorney General may investigate relevant facts, issue subpoenas under existing court rules, and apply to a court for an injunction (an order to stop a violation).

Money#

No publicly available information on estimated public or private costs.

  • The Department of Health must create a model label, but the bill gives no staffing or cost estimate.
  • Manufacturers would have to add labels to covered devices and packaging; no compliance-cost estimate is provided.
  • Courts may impose the specified civil penalties. The bill does not estimate how many violations or penalties there might be.

What is unclear#

  • “Prolonged use,” “clear and conspicuous,” and “similar product” are not defined. The bill sets a minimum type size but not a time limit for use or a required frequency for repositioning.
  • The bill does not explain how “per violation” would be counted.
  • The supplied materials do not include the current General Business Law, so existing warning rules and how they may overlap with this bill could not be verified.
  • The bill does not say how the Department of Health would develop the model label or whether it would consult manufacturers, health professionals, or families.

Case for#

  • The bill appears intended to alert caregivers to a possible risk from prolonged pressure and to give practical advice about limiting use and repositioning.
  • Requiring the warning on both the product and its retail packaging could make it visible before purchase and while the product is being used.
  • A model label from the Department of Health could provide manufacturers with a common starting point.

Case against#

  • The bill does not define “prolonged use” or say what amount of use is safe, so the warning may not give caregivers a clear limit.
  • Manufacturers would face a new labeling duty, but the bill provides no estimate of the cost or detail about how violations will be counted.
  • The bill allows penalties and court orders but does not set out a process for warning manufacturers or correcting a label before seeking enforcement.